Very Low Evidence
Research Overview
Dihexa Research for Alzheimer's Disease
An evidence-based overview of research examining Dihexa in the context of alzheimer's disease. This page synthesizes findings from peer-reviewed literature.
Research Summary
One study in APP/PS1 transgenic mice (Alzheimer's model) showed cognitive improvement with Dihexa via PI3K/AKT pathway activation. This represents early-stage preclinical research with no human validation.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Alzheimer's Disease
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Dihexa has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.